DiaMedica Therapeutics Inc (DMAC.OQ)
DMAC.OQ on NASDAQ Stock Exchange Capital Market
Change (% chg)
DiaMedica Therapeutics Inc is a Canada-based clinical-stage biopharmaceutical company, which focuses on recombinant proteins and monoclonal antibodies. The Company focuses on the discovery and development of treatments for stroke and other vascular diseases. It operates through segment, which is discovery and development of... (more)
Reuters.com is improving our Quote page. Click here to take a look and let us know what you think.
Earnings vs. Estimates
No consensus analysis data available.